focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,757.00
Bid: 1,756.50
Ask: 1,757.00
Change: 1.00 (0.06%)
Spread: 0.50 (0.028%)
Open: 1,743.50
High: 1,759.00
Low: 1,740.50
Prev. Close: 1,756.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Sachs Says Buy Royal Mail And Intertek

Fri, 07th Nov 2014 09:42

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
GOLDMAN RAISES BABCOCK INTERNATIONAL PRICE TARGET TO 1438 (1380) PENCE - 'BUY'
----------
GOLDMAN RESUMES ROYAL MAIL WITH 'BUY' - TARGET 575 PENCE
----------
GOLDMAN RAISES INTERTEK TO 'BUY' ('NEUTRAL') - TARGET 3440 (3240) PENCE
----------
GOLDMAN RAISES EXPERIAN TO 'NEUTRAL' ('SELL') - TARGET 1078 (985) PENCE
----------
TRADERS: NOMURA RAISES EXPERIAN PRICE TARGET TO 1,130 (1,100) PENCE - 'BUY'
----------
UBS CUTS COCA-COLA HBC TARGET TO 1,360 (1,450) PENCE - 'NEUTRAL'
----------
Nomura Cuts Coca-Cola HBC Price Target To 1,100p From 1,140p, Maintains Reduce
----------
UBS CUTS RSA INSURANCE PRICE TARGET TO 418 (427) PENCE - 'SELL'
----------
EXANE BNP RAISES RSA INSURANCE PRICE TARGET TO 430 (405) PENCE - 'UNDERPERFORM'
----------
UBS RAISES SCHRODERS PRICE TARGET TO 2,800 (2,400) PENCE - 'NEUTRAL'
----------
BERENBERG CUTS GLAXOSMITHKLINE PRICE TARGET TO 1540 (1575) PENCE - 'HOLD'
----------
CITIGROUP RAISES 3I GROUP PRICE TARGET TO 455 (430) PENCE - 'BUY'
----------
S&P CAPITAL IQ CUTS MORRISON TO 'SELL' ('HOLD') - TARGET 155 (195) PENCE
----------
LBBW RAISES ASTRAZENECA PRICE TARGET TO 3900 (3600) PENCE - 'SELL'
----------
NUMIS CUTS HSBC PRICE TARGET TO 700 (725) PENCE - 'ADD'
----------
NUMIS CUTS RANDGOLD RESOURCES PRICE TARGET TO 4,900 (5,100) PENCE - 'BUY'
----------
S&P CAPITAL IQ RAISES ASTRAZENECA PRICE TARGET TO 4700 (4500) PENCE - 'HOLD'
----------
FTSE 250
----------
GOLDMAN CUTS HAYS PRICE TARGET TO 153 (185) PENCE - 'BUY'
----------
TRADERS: GOLDMAN REMOVES HAYS FROM 'CONVICTION BUY LIST' - STILL 'BUY'
----------
GOLDMAN RAISES FIRSTGROUP PRICE TARGET TO 165 (160) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BERENDSEN PRICE TARGET TO 1170 (1132) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS MICHAEL PAGE TO 'NEUTRAL' ('BUY') - TARGET 467 (570) PENCE
----------
GOLDMAN CUTS HIKMA PHARMA TO 'NEUTRAL' ('BUY') - TARGET 2120 (2250) PENCE
----------
MORGAN STANLEY RAISES WILLIAM HILL TARGET TO 460 (425) PENCE - 'OVERWEIGHT'
----------
TRADERS: SOCGEN CUTS AVEVA GROUP PRICE TARGET TO 2000 (2250) PENCE - 'BUY'
----------
CHARLES STANLEY RAISES COBHAM TO 'HOLD' ('REDUCE')
----------
BARCLAYS CUTS LONMIN PRICE TARGET TO 190 (205) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS HALFORDS GROUP PRICE TARGET TO 385 (400) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS LANCASHIRE HLDGS PRICE TARGET TO 494 (575) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS INITIATES INFINIS ENERGY WITH 'OVERWEIGHT' - TARGET 275 PENCE
----------
TRADERS: JPMORGAN RAISES CRODA PRICE TARGET TO 2,300 (2,250) PENCE - 'NEUTRAL'
----------
HSBC CUTS JD WETHERSPOON PRICE TARGET TO 820 (850) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS TATE & LYLE PRICE TARGET TO 600 (610) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES BIG YELLOW GROUP PRICE TARGET TO 540 (470) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS UBM PRICE TARGET TO 670 (820) PENCE - 'BUY'
----------
CITIGROUP INITIATES POUNDLAND GROUP WITH 'BUY' - TARGET 350 PENCE
----------
TRADERS: JPMORGAN CUTS PLAYTECH TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 615 (860) PENCE
----------
MAIN MARKET AND AIM
----------
CITIGROUP INITIATES B&M WITH 'BUY' - TARGET 310 PENCE
----------
PANMURE RAISES LOOKERS PRICE TARGET TO 175 (166) PENCE - 'BUY'
----------
PANMURE RAISES FILTRONIC PRICE TARGET TO 23 (20) PENCE - 'HOLD'
----------
TRADERS: JPMORGAN CUTS PROMETHEAN TO 'UNDERWEIGHT' ('NEUTRAL')
----------
TRADERS: JPMORGAN RAISES GEM DIAMONDS TARGET TO 280 (270) P - 'OVERWEIGHT'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.